中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Immune Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Circulars - Proposals for General Mandates to Issue Shares and Repurchase Shares, Re-Election of Retiring Directors and Notice of Annual General Meeting
2025-04-28
Notification Letter to Non-Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
2025-04-28
Notification Letter to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply
2025-04-28
Next Day Disclosure Return - Others
2025-04-25
Next Day Disclosure Return - Others
2025-04-24
Next Day Disclosure Return - Others
2025-04-23
Inside Information - Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-Week Phase IIa Study Protocol to FDA
2025-04-23
Next Day Disclosure Returns - Share Buyback/Others
2025-04-17
Next Day Disclosure Returns - Share Buyback/Others
2025-04-16
Next Day Disclosure Return - Others
2025-04-15
«
2
3
4
5
»